UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2019

 

Commission File Number: 001-39034

 

BELLUS Health Inc.

(Name of registrant) 

 

 

275 Armand-Frappier Blvd.

Laval, Quebec

H7V 4A7 Canada

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

¨  Form 20-F

x  Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	BELLUS Health Inc.
Date: September 17, 2019	By:	/s/ Francois Desjardins
		Name:	Francois Desjardins
		Title:	Vice President, Finance

 

 

 

 

Form 6-K Exhibit Index

 

Exhibit Number		Document Description
99.1		News Release dated September 17, 2019. BELLUS Health Announces Exercise of Over-Allotment Option in Connection with Underwritten Public Offering of Common Shares.